Table I.
Correlation between clinicopathological characteristics and expression of lncRNA-XIST and LC3B in the NSCLC patients (n=50).
| Relative lncRNA-XIST expression | Relative LC3B expression | |||||
|---|---|---|---|---|---|---|
| Characteristics | High | Low | P-value | High | Low | P-value |
| Age (years) | 0.563 | 0.782 | ||||
| <45 | 15 (55.6) | 11 (47.8) | 14 (51.9) | 13 (56.5) | ||
| ≥45 | 12 (44.4) | 12 (52.2) | 13 (48.1) | 10 (43.5) | ||
| Sex | 0.773 | 0.783 | ||||
| Female | 12 (42.9) | 8 (36.4) | 12 (54.5) | 14 (50) | ||
| Male | 16 (57.1) | 14 (63.6) | 10 (45.5) | 14 (50) | ||
| Tumor size (cm) | 0.158 | 0.571 | ||||
| ≥5 | 16 (69.6) | 13 (48.1) | 13 (56.5) | 12 (44.4) | ||
| <5 | 7 (30.4) | 14 (51.9) | 10 (39.1) | 15 (55.6) | ||
| LNM | 0.156 | 0.272 | ||||
| Positive | 16 (61.5) | 9 (37.5) | 14 (60.9) | 12 (44.4) | ||
| Negative | 10 (38.5) | 15 (62.5) | 9 (39.1) | 15 (55.6) | ||
| TNM stage | 0.045 | 0.044 | ||||
| I–II | 7 (28) | 15 (60) | 8 (38.1) | 20 (69) | ||
| III–IV | 18 (72) | 10 (40) | 13 (61.9) | 9 (31) | ||
Data are expressed as n (%). LNM, lymph node metastasis.